GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Regulatory News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.40
Bid: 29.20
Ask: 29.90
Change: -0.35 (-1.18%)
Spread: 0.70 (2.397%)
Open: 29.50
High: 30.00
Low: 29.40
Prev. Close: 29.75
EKF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

19 Apr 2006 07:00

Embargoed: 19th April 2006, 07:00hrs International Brand Licensing Plc ("IBL" or the "Company") Final Results to the year ended 31 December 2005 Chairman's StatementHighlights: * Turnover for the year ended 31 December 2005 increased by ‚£1,026,000 to ‚£ 3,261,000 (2004: ‚£2,235,000) * Profit on ordinary activities before tax improved by ‚£1,482,000 to a profit of ‚£977,000 (2004: loss of ‚£505,000) * A gain of ‚£475,000 was made on the sale of the Mountain Equipment trademarks * Record sales of England replica kit and substantial growth opportunities ahead For the year ended 31st December 2005 I am delighted to report a substantialturnaround in the Group's fortunes. 2005 was a year of consolidation, cuttingoverheads, improving gross margin, eliminating debt, and producing a full yearprofit for the first time in the Group's history.The 45% increase in turnover is attributable to the exceptional sales of theAdmiral England cricket replica kit that increased by 90% to a record level of‚£2,525,000 for the year. Boosted by England's tremendous Ashes win overAustralia, the Admiral brand enjoyed unprecedented visibility throughout theyear, and this continued unabated this winter, culminating in the marvellousthird Test victory over India in March 2006.With the return Ashes Series in Australia this winter, followed by the ICCCricket World Cup in the Caribbean and the India UK tour next summer, the levelof exposure that will continue to be generated for Admiral will further enhancethe profile and brand value for the future.Against a backdrop of difficult trading conditions in the UK retail sector thatfailed to recover through the year, Admiral sales at ASDA were some 15% down on2004. Certain product categories such as footwear and sports equipmentcontinued to perform well, but clothing suffered due to the heavy discountingthat plagued the UK market for much of the year. With the FIFA World Cup Finalsin Germany this summer we expect Admiral's first half clothing sales at ASDA toshow an overall improvement on 2005.In December the Company entered into a new strategic alliance with @miral BV,its licensee for Benelux, Germany, and Austria. As part of a new ten yearlicense agreement for this key central European territory, @miral will use itsextensive design, development, and marketing resources to develop seasonalprogrammes on an annual basis for IBL's network of international licensees.The Company continues to seek Admiral licensee partners in other majorinternational markets, particularly in several of the developing Asianeconomies where a significant amount of work has been undertaken. Negotiationsin certain markets are progressing well, and focus will continue to be appliedon untapped potential for the Admiral brand where opportunities for futuregrowth are substantial.IBL is now in a strong position to further enhance shareholder value. TheAdmiral brand continues to grow around the world, and as kit sponsors to theEngland and West Indies cricket teams we believe we have substantialopportunities in the years ahead. Your Board looks forward to the future withgreat confidence.ADAM REYNOLDSChairman19th April 2006For further information please contact:Adam ReynoldsPaul FoulgerInternational Brand Licensing plcTel: 020 7823 1733Katie Ratner/John PriorCorporate SynergyTel: 020 7448 4400Group Profit and Loss AccountFor the year ended 31 December 2005 2005 2004 ‚£000 ‚£000 Turnover 3,261 2,235 Cost of sales (1,286) (561) Gross Profit 1,975 1,674 Administrative expenses (1,402) (1,963) Operating Profit/(Loss) 573 (289) Exceptional profit on sale of intangible 475 -asset Interest receivable 6 - Interest payable (77) (216) Profit/(Loss) on ordinary activities before 977 (505)tax Tax on profit on ordinary activities (142) (84) Retained Profit/(Loss) for the year 835 (589) Earnings/(Loss) per ordinary share Before exceptional items - Basic 1.1p (1.9p) - Diluted 1.1p (1.9p) After exceptional items - Basic 2.5p (1.9p) - Diluted 2.5p (1.9p)Group statement of total recognised gains and lossesFor the year ended 31 December 2005 2005 2004 ‚£000 ‚£000 Profit/(Loss) for the year 835 (589) Exchange differences (236) 28 Total recognised gains and losses relating to the 599 (561)year Group balance sheetat 31 December 2005 2005 2004 ‚£000 ‚£000 Fixed assets Intangible assets 3,471 5,952 Tangible assets 9 15 3,480 5,967 Current assets Stock 252 217 Debtors 828 364 Cash at bank and in hand 283 109 1,363 690 Creditors: amounts falling due within one year (1,129) (3,542) Net current assets/(liabilities ) 234 (2,852) Total assets less current liabilities 3,714 3,115 Capital and reserves Share capital 333 333 Share premium 3,048 3,048 Merger reserve 244 244 Profit and loss account 89 (510) Shareholders' funds 3,714 3,115Group statement of cash flowsAt 31 December 2005 2005 2004 ‚£000 ‚£000 Net cash inflow/(outflow) from operating activities 111 (430) Returns on investments and servicing of finance Interest paid (80) (224) Interest received 6 - Taxation UK Tax paid (59) (198) Foreign taxes received 48 - Capital expenditure and financial investment Purchase of intangible fixed assets (37) (82) Capital Income Sale of intangible fixed assets 2,772 - Net cash inflow/(outflow) from capital expenditure 2,735 (82) and financial investment Net cash inflow/(outflow) before financing 2,761 (934) Financing Repayment of bank borrowing (2,563) (250) Issue of ordinary shares - 1,329 Less expenses of issue - (111) Net cash (outflow)/inflow from financing (2,563) 968 Increase in cash in the year 198 34The financial information set out in this announcement does not constitutestatutory accounts within the meaning of Section 240 of the Companies Act 1985.Statutory accounts for the period ended 31 December 2005, containing anunqualified auditors' report will be filed with the Registrar of Companies.The Directors do not propose a payment of a dividend.This preliminary statement was approved by the Board on 19 April 2006ENDINTERNATIONAL BRAND LICENSING PLC
Date   Source Headline
22nd Jun 20224:36 pmRNSPrice Monitoring Extension
21st Jun 20227:00 amRNSDirector/PDMR Shareholding
20th Jun 20227:00 amRNSDistribution of shares in Verici Dx plc
13th Jun 20227:00 amRNSUpdate on strong cash position
9th Jun 20227:00 amRNSLaunch of EKF Link
23rd May 20227:00 amRNSCancellation of Treasury Shares and TVR
18th May 20221:25 pmRNSResult of AGM
18th May 20227:00 amRNSAGM Statement
3rd May 20227:00 amRNSPDMR/Director Dealings & Holding(s) in Company
25th Apr 20227:00 amRNSPosting of Annual Report & Accounts &Notice of AGM
11th Apr 20227:00 amRNSPurchase of Own Shares & Buyback Prog. Completion
8th Apr 20227:00 amRNSPurchase of Own Shares
7th Apr 20227:00 amRNSPurchase of Own Shares
6th Apr 20227:00 amRNSPurchase of Own Shares
5th Apr 20227:00 amRNSPurchase of Own Shares
4th Apr 20227:00 amRNSPurchase of Own Shares
1st Apr 20227:00 amRNSPurchase of Own Shares
31st Mar 20227:00 amRNSPurchase of Own Shares
30th Mar 20227:00 amRNSPurchase of Own Shares
29th Mar 20227:01 amRNSShare Buyback Programme
29th Mar 20227:00 amRNSFinal Results
25th Mar 20224:40 pmRNSSecond Price Monitoring Extn
25th Mar 20224:35 pmRNSPrice Monitoring Extension
18th Mar 20225:13 pmRNSHolding(s) in Company
7th Mar 20227:00 amRNSFurther Investment in Verici Dx plc
3rd Mar 20224:41 pmRNSSecond Price Monitoring Extn
3rd Mar 20224:36 pmRNSPrice Monitoring Extension
3rd Mar 20227:00 amRNSNotice of Results
31st Jan 20227:00 amRNSNon-executive Directorate Change
25th Jan 20227:00 amRNSTrading update
18th Jan 20227:01 amRNSStrategic partnership agreement with Yourgene
23rd Nov 20217:00 amRNSDirectorate Change
8th Nov 20211:01 pmRNSDirector/PDMR Shareholding
25th Oct 20217:00 amRNSDividend confirmation
12th Oct 20217:00 amRNSCompletion of ADL Health Acquisition
5th Oct 20213:00 pmRNSPDMR/ PCA Dealings
5th Oct 20213:00 pmRNSHolding(s) in Company
28th Sep 20217:00 amRNSAcquisition of Advanced Diagnostic Laboratory LLC
14th Sep 20217:00 amRNSHalf-year Report
25th Aug 20217:00 amRNSNotice of Results
21st Jul 20217:00 amRNSTrading Update
16th Jun 20217:00 amRNSChange of Adviser
7th Jun 202110:10 amRNSInvestor Presentations
26th May 20215:48 pmRNSTrellus Health plc: Successful Restricted Offer
20th May 20214:31 pmRNSTrellus Health plc: Confirmation of Issue Price
19th May 202112:58 pmRNSResult of AGM
19th May 20217:01 amRNSBoard Changes and Executive Performance Bonus
19th May 20217:00 amRNSAGM Statement
18th May 20217:00 amRNSTrellus Health plc: Intention to Float - AIM
5th May 202111:14 amRNSNotice of Change of AGM Venue and Dividend Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.